OCT 12, 2017 9:00 AM PDT

Circulating biomarkers - what matters for the isolation of biomarkers from Liquid Biopsy samples

Speaker
  • Global Product Manager, QIAGEN
    Biography
      Dr. Verena Schramm is a Global Product Manager for RNA sample extraction and Liquid Biopsy at QIAGEN GmbH, Germany. Before taking over these product responsibility, she was a Global Product Manager for NGS library preparation products at QIAGEN.
      Verena holds and M.Sc. in Molecular Biology and a PhD in Bioinformatics. During her PhD at EMBL Heidelberg she studied the impact of copy-number variation during the evolution of non-human primates using Next-Generation Sequencing.
      Before joining QIAGEN, Verena worked as a Sales and Business Development Manager DACH, NL and as a Subject Matter Expert at Sophia Genetics a company focusing on the analysis of clinical NGS data in Diagnostics.

    Abstract

    The analysis of circulating biomarkers in a patient’s blood holds significant potential for early disease detection and disease monitoring. Circulating DNA is the most commonly studied biomarker in the context of Liquid Biopsy research. However, in the last couple of years, free-circulating RNA has gained more attention for biomarker analysis and interpretation.

    In this webinar, we will discuss the different types of circulating RNA biomarkers studied in Liquid Biopsy samples. A special focus will be given to the challenges and solutions for circulating RNA isolation.


    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 02, 2020 7:00 AM PDT
    C.E. CREDITS
    SEP 02, 2020 7:00 AM PDT
    DATE: September 2, 2020 TIME: 03:00pm PDT, 6:00pm EDT Spatial omics is an expanding collection of methods to examine biological molecules in their geographical context. By retaining the prec...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    OCT 12, 2017 9:00 AM PDT

    Circulating biomarkers - what matters for the isolation of biomarkers from Liquid Biopsy samples


    Specialty

    Biomarkers

    Antibodies

    Immunology

    Bioinformatics

    Gene Expression

    Cancer Research

    Oncology

    Drug Discovery

    Cell Culture

    Biotechnology

    Virology

    Genomics

    Cancer Therapeutics

    Dna Sequencing

    Personalized Medicine

    Geography

    North America25%

    Europe25%

    Africa25%

    Registration Source

    Website Visitors75%

    Job Title

    Student67%

    Facility/Department Manager33%

    Organization

    Biotech Company50%

    Academic Institution25%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more